The effects of dichloroacetate (DCA) on brain lactate, intracellular pH (pHJ, phosphocreatine (PCr), and ATP during 60 min of complete cerebral ischemia and 2 h of reperfusion were investigated in rats by in vivo IH and 31p magnetic resonance spectroscopy; brain lactate, water content, cations, and amino acids were measured in vitro after reperfusion. DCA, 100 mg/kg, or saline was infused before or immediately after the ischemic period. Preischemic treatment with DCA did not affect brain lac tate or pHi during ischemia, but reduced lactate and in Abbreviations used: ANOVA, analysis of variance; BBB, blood-brain barrier; DCA, dichloroacetate; NAA, N-acetylas partate; NMDA, N-methyl-D-aspartate; NMR, nuclear magnetic resonance; PCr, phosphocreatine; PDHC, pyruvate dehydroge nase complex; pHi' intracellular pH.
creased pHi after 30 min of reperfusion (p < 0.05 vs. controls) and facilitated the recovery of PCr and ATP during reperfusion. Postischemic DCA treatment also re duced brain lactate and increased pHj during reperfusion Treatments that lower brain lactate levels during ischemia or reperfusion could prevent or reduce subsequent brain injury (Hossmann and Kleihues, 1973; Rehncrona et al., 1981; Siesjo, 1988) . Dichlo roacetate (DCA) has been shown to decrease lac tate levels in many tissues (Stacpoole, 1989) by ac tivating the pyruvate dehydrogenase complex (PDHC) (Whitehouse and Randle, 1973) . PDHC, the mitochondrial multienzyme complex that cata lyzes the oxidation of pyruvate to acetyl CoA, is activated by PDHC phosphatase and inactivated by PDHC kinase (Linn et al., 1969) , which, in turn, is noncompetitively inhibited by DCA resulting in un restricted activation of the PDHC (Crabb et aI., 1982) . Since lactate and pyruvate are intercon verted by lactate dehydrogenase, DCA lowers the lactate level by increasing substrate utilization of pyruvate, especially when glucose and O 2 availabil ity are reduced by ischemia. Serum and brain PDHC activity is increased after DCA administra tion in rats (Evans and Stacpoole, 1982; Abemayor et al., 1984; Kuroda et al., 1984) . DCA crosses the blood-brain bar rier (BBB) in rats (Evans, 1983) .
In normoglycemic or hyperglycemic rats sub jected to 15 min of incomplete ischemia (Cardell et aI., 1989; Lundgren et aI., 1990) , PDHC activity increased during ischemia but was depressed after 15 min of reperfusion despite preischemic treatment with DCA (Cardell et al., 1989) . Preischemic admin istration of DCA did not affect brain lactate, ATP, or phosphocreatine (PCr) in hyperglycemic rats (Colohan et al., 1986) or brain lactate in fasted rats during incomplete isch emia. DCA given after incomplete ischemia, how ever, significantly lowered brain lactate levels after reperfusion in rats (Biros et al., 1986; Kaplan et al., 1987) . In fed gerbils, DCA injected before incom plete brain ischemia had no effect on the initial re covery of lactate, ATP, and PCr, but enhanced postischemic reactivation of PDHC and prevented secondary failure of energy metabolism in the cau date during reperfusion (Katayama and Welsh, 1989) .
In this study, in vivo I H and 31p nuclear magnetic resonance (NMR) spectroscopy was used to evalu ate the effects of preischemic and postischemic treatment with DCA on the time course of changes in brain lactate, intracellular pH (pH), and phos phorus energy metabolites during 60 min of com plete cerebral ischemia and 2 h of reperfusion in rats for correlation with brain lactate, water content, cation concentrations, and amino acid levels mea sured in vitro at the end of reperfusion.
METHODS

Surgical preparation
The protocol used in this study was approved by the Committee on Animal Research, University of California, San Francisco. Male Sprague-Dawley rats (300--400 g), fed ad libitum, were anesthetized in a closed chamber containing 3% isoflurane and 97% O2, intubated with a 16-gauge plastic angiocatheter, paralyzed with pancuro nium bromide (I mg/kg), and connected to a rodent ven tilator (Harvard Apparatus, Millis, MA, U.S.A.). Anes thesia was maintained with 1.5% isoflurane in 30% O 2 and 70% N20 throughout the study. The respiratory rate and volume were adjusted to keep the arterial pH at 7.4, Peo 2 at 35-40 mm Hg, and P02 > 100 mm Hg. Arterial pressure, glucose, pH, and blood gases were monitored through a femoral arterial catheter connected to a pressure trans ducer and an oscilloscope (Hewlett-Packard, Palo Alto, CA, U.S.A.). One femoral vein was cannulated with PE-50 plastic tubing for infusion of saline and DCA.
Scalp, periosteum, and temporal muscles were re flected. Through small bilateral cranial windows in the temporal region, thin, platinum wire electrodes were placed epidurally and glued to the skull. The EEG was monitored throughout the experiment with a Neurotrac monitor (Interspec, Conshohocken, PA, U.S.A.). Rectal temperature was monitored and maintained at 37-38°C with a temperature-controlled plastic water jacket. Mon itoring brain temperature is not feasible during NMR spectroscopy.
The seven-vessel occlusion technique used to induce complete cerebral ischemia followed by reperfusion has been described in detail (Faden et aI., 1990; Shirane et al., 1991) . Briefly, both external carotid and pterygopalatine arteries and the basilar artery were exposed and occluded by electrocautery. The common carotid arteries were ex-posed and isolated from adjacent tissue; Silastic tubing was looped around each artery and the sternomastoid muscle to form a snare for remote-controlled arterial oc clusion. Complete cerebral ischemia was induced by ap plying tension to the carotid artery snares; ischemia was confirmed by a transient increase of the arterial blood pressure and flattening of the EEG. Reperfusion was ac complished by releasing tension on the carotid snares and confirmed by observing restoration of pulsatile carotid artery flow. Previous local cerebral blood flow studies with this model have confirmed cerebral circulatory ar rest during occlusion and postischemic reperfusion ex cept for scattered punctate areas of "no-reflow" without induction of hemodilution, hypertension, or hyperosmo lar diuresis (Shirane et al., 1991) ; however, some en hancement of recirculation was observed after the admin istration of mannitol (Shirane and Weinstein, 1992) .
NMR spectroscopy
In vivo NMR spectroscopy was performed with a 5.6-T spectrometer, a horizontal-bore magnet 4 inches in diam eter, a custom-built console, and a Nicolet 1180 data sys tem. A two-turn, elliptical surface coil (10 x 14 mm), double-tuned to IH (236.8 MHz) and 31p (95.8 MHz) fre quencies, was placed over the calvarium (Chang et al., 1987a) . The homogeneity of the magnetic field over the sample was optimized by shimming on the water proton signal (observed through the IH channel of the coil) to a line width of <0.15 ppm. IH and 31p spectra were ac quired simultaneously in 5-min blocks (Chang et aI., 1987b; Chang et aI., 1990) . The IH spectrum was obtained using a pre saturation-Hahn-spin-echo pulse sequence with an echo delay of 60 ms. The water signal was pre saturated by a low-power transmitter pulse (100 ms). For 31p spectroscopy, a selective saturation pulse sequence was used. Selective saturation was accomplished by set ting the decoupler frequency 15 ppm downfield from PCr resonance and turning the decoupler on for 500 ms. The IH and 31p pulse sequences were then interleaved and applied repetitively for 5 min. Usually, 200 free-induction decays were collected for each of the 1 H and 31 P spectra with a spectral width of ±3,012 Hz and 4 K data points.
After baseline IH and 31p spectra were acquired, se quential sets of NMR data were obtained every 5 min during ischemia and reperfusion. Chemical shifts were referenced to the N-acetylaspartate (NAA) resonance at 2.02 ppm for I H spectra or to the PCr resonance at 0 ppm for 31p spectra. Peak areas were calculated by fitting the peaks with the NTCCAP program on the Nicolet 1180 data system. Intracellular pH was calculated as pHi = 6.77 + log ([8 -3.27]/[5.78 -8]), where 8 is the chem ical shift of Pi with respect to PCr (Seo et aI., 1983) . The lactate concentration (f-lmol g -I brain tissue wet weight) was estimated as: 19.6 x (peak area of lactate)/(peak area of NAA), where 19.6 is a correction factor derived by correlating in vivo NMR peak areas with results of in vitro biochemical assays (Chang et aI., 1987b; Chang et aI., 1990) .
Experimental groups
DCA (Sigma, St. Louis, MO, U.S.A.) solution was freshly prepared for each experiment by titration to neu tral pH with 6 N NaOH. DCA, 100 mg/kg, was dissolved in 1 ml of saline solution and infused over 10 min (in preliminary studies, a rapid bolus infusion at this concen tration caused blood pressure to drop).
Two treatment groups were studied. One group re ceived DCA 30 min before the induction of ischemia. The other received DCA at the start of reperfusion after 60 min of ischemia. The respective control groups received saline infusions instead of DCA. After 2 h of reperfusion, each brain was rapidly funnel-frozen in situ with liquid nitrogen, removed, and stored at -70°C until specimens containing mostly cortex were processed for neurochem ical assays .
Blood chemistry
Serum lactate concentration was measured by an en zymatic assay. Whole blood was deproteinized by the addition of cold 8% perchloric acid and centrifuged. The supernatant was analyzed with a lactate dehydrogenase kit (Sigma) that measures the formation of NADH spec trophotometrically at 340 nm. Serum glucose was mea sured with a glucose analyzer (Model 23A, Yellow Springs Instruments, Yellow Springs, OH, U.S.A.).
Neurochemical assays
Brain water content was measured by the wet-dry weight technique. N a +, K +, or Mg 2 + concentrations were determined by atomic absorption spectrophotome try (Lemke et al., 1987) . The brain lactate level in the postischemic treatment group was determined in vitro by fluorometry (Lowry and Passonneau, 1972) in samples from the frontoparietal cortex sonicated in 0.03 N HCl. In the preischemic treatment group, amino acid analyses were performed as described elsewhere (Graham et al., 1990) with HPLC and electrochemical detection and stan dardized with protein levels determined by a method (Bradford, 1976 ) that yields levels higher than those ob tained with other techniques. The results were compared with those obtained with identical methods in a previ ously reported sham-operated group .
Statistical analysis
The percentage change from baseline peak areas was calculated for PCr, Pi' and, ATP at each time point (the midpoint of a 5-min collection interval) and reported as the mean ± SD for each group. Physiological and bio chemical values are also reported as mean ± SD. Com parisons of control and treatment groups for each time point were made by analysis of variance (ANOV A) fol lowed by Dunnett's t test. Correlation between changes in lactate and pH was tested by linear regression analysis.
RESULTS
Physiological variables
There were no statistically significant differences between groups in arterial blood gases, or serum pH before, during, or after the ischemic period. MABP was comparable in all four groups before and during ischemia, but during reperfusion it was -20% lower than baseline values in the preischemic DCA treat ment and control groups. Within 30 s after the start of ischemia, MABP increased transiently in all rats; the EEG tracing flattened and did not recover dur ing 2 h of reperfusion.
Adequate samples for measurement of serum lac tate were not obtained from all rats in both control groups; therefore, preischemic (n = 3) and post-J Cereb Blood Flow Metab, Vol. 12, No.6, 1992 ischemic (n = 4) saline-infused rats were combined into a single group for this comparison. Before isch emia, there were no differences in serum lactate between groups. After 30 min of ischemia, serum lactate was significantly lower in the preischemic DCA treatment group (n = 4) than in controls (0.7 ± 0.3 vs. 1.0 ± 0.3 nmol/L, p < 0.05). Thirty min utes after the onset of reperfusion, serum lactate was significantly lower in both the preischemic and postischemic DCA treatment groups than in con trols (0.5 ± 0.1 and 0.5 ± 0.2, respectively, vs. 1.0 ± 0.3 nmol/L, p < 0.05).
Magnetic resonance spectroscopy
Representative in vivo I H and 31p NMR spectra from a control rat during ischemia and reperfusion are shown in Fig. 1 . During the first 5 min of isch emia, PCr and ATP were rapidly depleted, Pi and lactate increased markedly, and pHi ·decreased sub stantially. After 10 min of ischemia, phosphorus en ergy metabolites were totally depleted and re mained so for the rest of the ischemic period. Within 20 min after blood flow was restored, phos phorus energy metabolites gradually began to re cover; lactate recovery started within 30 min. How ever, substantial recovery was observed only after 1 h of reperfusion. Phosphorus energy metabolites recovered more rapidly than lactate and pHi' After 2 h of reperfusion, all measured metabolites and pHi had returned nearly to baseline levels. Throughout the experiment, lactate and pHi correlated closely over time in each group (preischemic DCA group, r = 0.962; saline controls, r = 0.927. Postischemic DCA group, r = 0.949; saline controls, r = 0.946).
Preischemic DCA treatment
The time course of changes in lactate and pHi in the preischemic DCA treatment and control groups is shown in Fig. 2 . There was no significant differ ence in lactate levels of pHi before or during isch emia between the two groups. However, lactate levels were significantly lower in treated rats than in controls between 15 and 90 min of reperfusion, and pHi was significantly higher in treated rats between 15 and 80 min of reperfusion. After 2 h of reperfu sion, there was no significant difference in lactate levels of pHi between the treatment group and con trols.
The time course of changes in phosphorus energy metabolites is shown in Fig. 3 . During ischemia, there were no significant differences in PCr, A TP, or Pi between the preischemic DCA treatment group and controls; PCr and A TP were totally de pleted in both groups and Pi increased markedly. After 30 min of reperfusion, however, PCr and ATP were significantly higher and Pi was significantly 'i 3 lower in the treated rats. After 2 h reperfusion, there were no significant differences in PCr, A TP, or Pi between the treatment group and controls.
The time course of changes in lactate and pHi in the postischemic DCA treatment group and control are shown in Fig. 4 . As expected, there were no significant differences in lactate, pHi ' or metabo lites before or during ischemia. Between 40 and 120 min of reperfusion, however, lactate levels were significantly lower in the treated rats than in con trols and, except at 70 and 100 min, pHi was signif icantly higher in treated rats between 30 and 110 min of reperfusion. Postischemic administration of DCA had little significant effect on phosphorus en- 
Neurochemistry
There was a highly significant difference in brain lactate levels in vivo between the postischemic DCA treatment group and controls [50.12 ± 12.45 vs. 92.27 ± 31.35 nmol/mg protein (5.0 ± 1.1 vs. 9.2 ± 3.1 f.Lmol g-l brain wet weight), p = 0.008]. Al though there was evidence of edema formation in both groups, there were no statistically significant differences in brain water content or in Na + , K + , and Mg 2 + concentrations between either DCA treatment group and saline controls. Analysis of brain amino acid levels in the pre- Asterisks indicate significant differ ences between the control and treat ment groups.
DISCUSSION
ischemic DCA treatment group, a sham-operated group, and saline-injected controls showed no dif ferences in aspartate, glycine, or -y-aminobutyric acid levels between groups. The glutamate levels, however, were significantly higher in the DCA treated rats than in the saline controls (251.5 ± 21.5 vs. 151.2 ± 49.6 nmollmg protein; p < 0.05). There was no significant difference in glutamate levels be tween the sham-operated rats and the DCA treat ment group. Thus, DCA prevented a decrease in tissue glutamate during ischemia and reperfusion.
The major finding of NMR spectroscopy in this study was the faster recovery from lactic acidosis during reperfusion after 60 min of complete cerebral ischemia in DCA-treated rats than in controls. These in vivo results suggest that enhancement of PDHC activity by preischemic or postischemic DCA treatment accelerates the recovery of lactate and pHi levels during reperfusion even after 1 h of ischemia. Although increase in PDHC activity might also improve mitochondrial bioenergetics and increase ATP production, which could enhance membrane Na + IH+ exchange, this alone is unlikely to account for the effect on pHj observed, because ischemic lactate concentrations are in the 20 mmol range. As expected, no metabolic differences be tween treatment and control groups were observed during ischemia when O2 and DCA delivery ceases and PDHC kinase activity may be reduced or ar rested (Colohan et aI., 1986) . Only when substrates were replenished during reperfusion were DCA's effects on lactic acidosis demonstrable, beginning Vol. 12, No.6, 1992 20-30 min after the start of reperfusion. The re sponse was slower in the postischemic DCA treat ment group, perhaps because drug infusion was not completed until 10 min after the onset of reperfu sion. The possible effect of preischemic DCA treat ment on the severity and rate of onset of lactic ac idosis may have been missed because of the imme diate onset of complete ischemia; however, the trend toward lower lactate levels and less variability in lactate and pHj (Fig. 2) suggests that there might have been a slight effect during ischemia as well. The most substantial indirect metabolic effects of DCA were the accelerated recovery rates of Pi> PCr, and ATP, beginning 10 min after the onset of reperfusion in the preischemic treatment group, even before the effect on lactic acidosis occurred. It is possible that DCA preserved mitochondrial integ rity during or immediately after ischemia by pro tecting against the inhibitory metabolic effects of lactate accumulation or acidosis (Katayama and Welsh, 1989; Lundgren et aI., 1990; Rehncrona et aI., 1981) . Alternatively, through its effects on lactic acidosis, DCA might indirectly increase cerebral blood flow or directly enhance creatine kinase ac tivity and oxidative phosphorylation. Of considerable interest was the observation of DCA ' s effects on the recovery from lactic acidosis despite the absence of improvement in energy me tabolism in the postischemic treatment group. This may have occurred as a result of selective mitro chondrial enzyme damage during ischemia before DCA was administered. The finding of substantial reduction in brain lactate in vitro at sacrifice con firms the effect of DCA. These results also confirm the rapid permeability of DCA through the blood brain barrier during reperfusion, as a substantial treatment effect on lactate and pHi was observed only 30 min after the onset of drug administration and reperfusion.
Release of intracellular glutamate as reflected by the reduction of total tissue levels comparable to those in saline controls in this study is believed to be a major and potentially irreversible cytotoxic re sponse to ischemia (Graham et aI., 1990; Ben veniste, et aI., 1989) . Maintenance of tissue gluta mate levels could reflect a neuroprotective effect of the reduction of lactic acidosis by DCA because glutamate is lost from injured cells. Possible expla nations for this effect include prevention of gluta mate release or reduction of glutamate catabolism because of impaired cellular energy metabolism (Erecinska et aI., 1984) . It is not known whether decline of extracellular glutamate levels during reperfusion is due to washout or metabolism or both.
Similar results were reported in our previous studies with this model after preischemic treatment with the opiate-receptor antagonist nalmefene, which may reduce excitotoxin release by enhancing recovery of energy metabolism (Faden et aI., 1990) . Conversely, the failure of DCA to influence post ischemic edema as measured by water content and cation concentration may be due to persistent im pairment of energy-dependent membrane cation regulatory mechanisms. Although lower DCA doses (25 mg/kg) have been used for studies of brain ischemia, the higher doses used in this study (100 mg/kg) are considered more effective (Dimlich et aI., 1989) . The drug has a half-life in rats of 3 h in plasma and 10 h in tissue (Evans, 1983) . Therefore, the time frame of this study (60 min of complete ischemia and 2 h of reperfusion) should have been well within the range of maximum DCA effective ness to observe therapeutic differences in metabolic recovery rates (Shirane et aI., 1988; Chang et aI., 1990) .
The excellent correlation between NMR mea surements of lactate and pHi throughout the exper iment in all groups suggests that the effects of isch emia on lactate are coupled to changes in pHi' It is not known whether lactate elevation is a marker or an agent of cell necrosis, and it is unclear whether the lactate anion or the hydrogen ion or both are cytotoxic during or after ischemia. Histological studies in nonischemic rat brain have identified an extracellular pH threshold of 6.0 for necrosis due to injection of acidic solutions not containing lactate (Kraig et aI., 1987) . Furthermore, NMR studies have shown that normoxic, hypercarbic rats with a pHi of 6.2 recovered neurologically without histo logical evidence of neuronal injury (Xu et aI., 1991) . Since pHi in this study remained above 6.2 during ischemia, the postischemic enhancement of meta bolic recovery after reduction of elevated lactate levels by DCA implies that attenuation of the lac tate increase rather than elevation of pHi may be the most important direct mechanism of metabolic pro tection observed in this study.
